Prot #BAY 98-7196/15832: A randomized, double-blind, double-dummy, parallel-group, multi-center phase IIb study to assess the efficacy and safety of different dose combinations of an aromatase inhibitor and a progestin in an intravaginal ring versus place

Project: Research project

Project Details

StatusFinished
Effective start/end date1/13/151/13/18

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (Prot #BAY 98-7196/15832)